SAN DIEGO , Sept. 2, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme") today announced that Dr. Helen Torley, President and Chief Executive Officer, and Darren Snellgrove,...
1 Mid-Cap Stock on Our Watchlist and 2 We Avoid
3 Market-Beating Stocks for Long-Term Investors
1 Healthcare Stock with Exciting Potential and 2 We Avoid
2 Mid-Cap Stocks with Solid Fundamentals and 1 Facing Challenges
SAN DIEGO , Aug. 18, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme") today announced the election of Dannielle Appelhans to its Board of Directors. Ms. Appelhans brings...
The Top 5 Analyst Questions From Halozyme Therapeutics’s Q2 Earnings Call
HALO Q2 Deep Dive: Royalty Diversification and New Pipeline Drive Upgraded Guidance
Halozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know
1 Profitable Stock to Research Further and 2 We Ignore